AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Vanda Pharmaceuticals Inc. Director's Dealing 2020

Feb 19, 2020

33390_dirs_2020-02-19_13f51a77-73d9-4454-a56d-76b8fc84aebe.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Vanda Pharmaceuticals Inc. (VNDA)
CIK: 0001347178
Period of Report: 2020-02-14

Reporting Person: Mitchell Stephen Ray (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	200	Direct